中文名称：CDKN1B抗原（重组蛋白）

英文名称：CDKN1B Antigen (Recombinant Protein)

储存：冷冻（-20℃）

相关类别：抗原

概述

Fusion protein corresponding to a region derived from 1-198 amino acids of human CDKN1B

技术规格

Full name:

cyclin dependent kinase inhibitor 1B

Synonyms:

KIP1; MEN4; CDKN4; MEN1B; P27KIP1

Swissprot:

P46527

Gene Accession:

BC001971

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).

展开全部

CDKN1B抗原（重组蛋白）说明书
下载

金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meeting

021-54845833/15800441009

ELISA试剂盒

PCR试剂盒

生化试剂盒

农残检测试剂盒

细胞库

基础培养基

完全培养基

原代细胞

细胞专用培养基

细胞系

菌株

生化试剂

病理染色液

科研抗体

标准品

血清

形态病理检测

分子病理

超微病理

产品中心

最新产品

相关文章

CDKN1B抗原（重组蛋白）

Full name:	cyclin dependent kinase inhibitor 1B
Synonyms:	KIP1; MEN4; CDKN4; MEN1B; P27KIP1
Swissprot:	P46527
Gene Accession:	BC001971
Purity:	>85%, as determined by Coomassie blue stained SDS-PAGE
Expression system:	Escherichia coli
Tags:	His tag C-Terminus, GST tag N-Terminus
Background:	This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).